Viridian Therapeutics, Inc. VRDN Operating margin

Operating margin at other companies

AmgenAMGN

30%+6.5pp

RegenxbioRGNX

-94.1%-9.3pp

Zevra Therapeutics, Inc.ZVRA

-103.9%-43.0pp

Shattuck Labs, Inc.STTK

-5,266.4%-9,520pp

Krystal Biotech, Inc.KRYS

42.8%+10.2pp

BioCryst PharmaceuticalsBCRX

-33.3%-43.0pp

FAQ

What is Viridian Therapeutics, Inc.'s operating margin?

Viridian Therapeutics, Inc. (VRDN) reported operating margin of -569.7% in Q2 2026.

How has Viridian Therapeutics, Inc.'s operating margin changed year-over-year?

Viridian Therapeutics, Inc.'s operating margin increased by 99.5% year-over-year, from -121,831.1% to -569.7%.

What is the long-term trend for Viridian Therapeutics, Inc.'s operating margin?

Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s operating margin has grown at a -45.3% compound annual growth rate (CAGR), from -10,512.4% to -512.9%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.